Oncodesign Precision Medicine Société anonyme (EPA:ALOPM)
France flag France · Delayed Price · Currency is EUR
0.4650
+0.0040 (0.87%)
Last updated: May 14, 2026, 12:34 PM CET

EPA:ALOPM Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22
87133012
Market Cap Growth
24.28%-42.44%-56.74%155.14%-
Enterprise Value
12121123-
Last Close Price
0.460.410.711.811.70
PE Ratio
1.521.36---
Forward PE
0.110.21---
PS Ratio
4.624.137.9317.241.42
PB Ratio
---30.218.131.00
P/TBV Ratio
---11.791.07
EV/Sales Ratio
6.876.387.0113.18-
EV/EBITDA Ratio
1.451.35---
EV/EBIT Ratio
2.182.03---
Debt / Equity Ratio
---17.652.390.22
Net Debt / Equity Ratio
---5.37-0.41-0.91
Net Debt / EBITDA Ratio
---0.310.167.45
Asset Turnover
--0.120.10-
Quick Ratio
--2.393.454.10
Current Ratio
--2.533.534.14
Return on Equity (ROE)
---442.13%-104.58%-
Return on Assets (ROA)
---35.69%-35.51%-
Return on Capital Employed (ROCE)
---107.20%-79.20%-11.20%
Earnings Yield
65.59%73.40%-55.58%-26.98%-1.97%
Buyback Yield / Dilution
---9.16%0.48%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.